IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.
Senior Commercial Buyers are a sophisticated lot and will be aware that AffiDX is a brand new product that may not yet have all of its i's and t's. They'll be more interested in a product that actually works ....rather than tossing up a Chinese Panda coin.
Who'd have thought a "populist" US web site would give a more balanced view:
https://www.zerohedge.com/markets/fate-world-will-be-previewed-uk
Rupert Soames spent 15 years at GEC in the avionics and computing department before accepting the CEO's job at Serco in 2014....then on the brink of collapse. He's recovered the company ....against all the odds. He's now considered one of the finest managers of his generation. And he's not responsible for his birth.
gemstar.....commercials will be employing professional buyers who will understand exactly the product they are looking at.If Avacta assures them the Indian variant will be identified it's highly unlikely a business that actually wants the product will regard that as a show stopper. Airlines in particular will want the most accurate test available. And are also highly unlikely to trust trust ANYTHING out of China.